Four cannabis companies Shango, Futureworks, Theraplant and True Harvest, went public via a merger with Greenrose Acquisition, a SPAC, in a $210m deal. In addition, a maximum of $110m in earnouts could be paid out through 2024, consisting of $75m in stock and $35m in debt. “Today marks an important milestone for Greenrose. Becoming a public company provides us with an opportunity to accelerate both our organic and M&A expansion plans as we work to build a platform of cannabis assets around award-winning, high-quality flower. We are grateful to our shareholders and our team for continuing to support us as we reach this exciting moment," Mickey Harley, Greenrose CEO and Director.